|
(Health-NewsWire.Net, June 24, 2015 ) This report covers the present scenario and the growth prospects of the global cancer vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various therapeutic and prophylactic cancer vaccines.
This report covers the present scenario and the growth prospects of the global cancer vaccines market for the period 2015-2019 in the following three regions:
Americas: The principal countries focused upon in this region are the US, Canada, Mexico, and Brazil
EMEA: The principal countries focused upon in this region are the UK; Germany; Italy; France; Spain and Middle Eastern and African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and UAE
APAC: The principal countries focused upon in this region are Japan, China, Australia, Singapore, South Korea, and India. APAC is one of the major markets that is untapped by the leading vendors
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
The report, Global Cancer Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the global cancer vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Cancer vaccines are biological preparations that stimulate or strengthen a person's immune system against cancer. Cancer vaccines are usually administered intravenously. They can be used in both adults and children. The vaccines can be broadly classified into two: prophylactic and therapeutic vaccines. Prophylactic vaccines are used for the prevention of cancer, whereas therapeutic vaccines are used for treatment of cancer.
The analysts forecast the global cancer vaccines market to grow at a CAGR of 27.24% over the period 2014-2019.
Purchase a Report Copy at http://www.rnrmarketresearch.com/contacts/purchase?rname=393301 .
Key Regions
Americas
APAC
EMEA
Key Vendors
Dendreon
GlaxoSmithKline
Merck
Other Prominent Vendors
Aduro BioTech
Advantagene
Advaxis
Agenus
AlphaVax
Altor BioScience
Amgen
Antigen Express
Argos Therapeutics
AVAX Technologies
Bavarian Nordic
Biothera
Bristol-Myers Squibb
Celldex Therapeutics
Cel-Sci
CureVac
Cytos
Galena Biopharma
Genexine
GlobeImmune
Gradalis
Heat Biologics
Immatics
ImmunoCellular Therapeutics
Immutep
Inovio Pharmaceuticals
Isa Pharmaceuticals
Juvaris Biotherapeutics
MedImmune
NewLink Genetics
Northwest Biotherapeutics
NovaRx
OncoThyreon
Oncovir
Oxford BioMedica
Prima BioMed
Progenics
Provectus Biopharmaceuticals
Sanofi
Sotio
Transgene
Ubivac
Vaccinogen
Vaxon Biotech
Vical
Inquire before Buying at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=393301 .
Market Driver
Increased Prevalence of Cancers
Market Challenge
Cold Chain Management
Market Trend
Strategic Alliances
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be
What are the key market trends
What is driving this market
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the key vendors
What are the strengths and weaknesses of the key vendors
Inquire for Discount at http://www.rnrmarketresearch.com/contacts/discount?rname=393301 .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
RnR Market Research
Ritesh Tiwari
1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
